2024 ICD-10-CM Diagnosis Code N62

Hypertrophy of breast

Short Description:
Hypertrophy of breast
Is Billable?
Yes - Valid for Submission
Code Navigator:

Code Classification

  • Diseases of the genitourinary system
    • Disorders of breast
      • Hypertrophy of breast

N62 is a billable diagnosis code used to specify a medical diagnosis of hypertrophy of breast. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Atypical ductal hyperplasia of breast
  • Atypical hyperplasia of breast
  • Atypical lobular hyperplasia of breast
  • Breast lobule hyperplasia
  • Drug-induced gynecomastia
  • Drug-induced gynecomastia
  • Familial juvenile hypertrophy of the breast
  • Finding related to development of the breasts
  • Gigantomastia
  • Gynecomastia
  • Gynecomastia
  • Gynecomastia
  • Gynecomastia
  • HCG-induced gynecomastia
  • Hyperplasia of mammary duct
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of breast
  • Hypertrophy of gland of Montgomery
  • Idiopathic gynecomastia
  • Infantile breast hypertrophy
  • Large breast
  • Mammary digital nail syndrome
  • Massive pubertal hypertrophy of breast
  • Overdeveloped breasts
  • Pseudoangiomatous stromal hyperplasia of breast
  • Pubertal breast hypertrophy
  • Pubertal gynecomastia
  • Size of breast - finding
  • Thelarche

Clinical Information

  • Gynecomastia-. enlargement of the breast in the males, caused by an excess of estrogens. physiological gynecomastia is normally observed in newborns; adolescent; and aging males.
  • 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency|17 Beta HSD3 Deficiency|17 beta HSD3 Deficiency|Pseudohermaphroditism, Male, with Gynecomastia-. decreased activity of the steroidogenic enzyme, 17-beta-hydroxysteroid dehydrogenase, associated with mutation(s) in the hsd17b3 gene, leading to reduced testosterone production.
  • Grade 1 Gynecomastia, CTCAE|Grade 1 Gynecomastia-. asymptomatic
  • Grade 2 Gynecomastia, CTCAE|Grade 2 Gynecomastia|Grade 2 Gynecomastia-. symptomatic (e.g., pain or psychosocial impact)
  • Grade 3 Gynecomastia, CTCAE|Grade 3 Gynecomastia|Grade 3 Gynecomastia-. severe symptoms; elective operative intervention indicated
  • Gynecomastia-. a non-neoplastic focal or diffuse proliferation of glandular tissue of breast in males.
  • Gynecomastia, CTCAE 5.0|Gynecomastia|Gynecomastia|Gynecomastia (Priority 2)-. a disorder characterized by excessive development of the breasts in males.
  • Pathological Gynecomastia-. gynecomastia that is due to exogenous substances or disease processes.
  • Pubertal Gynecomastia|Transient Gynecomastia|Transient Gynecomastia-. gynecomastia that occurs during puberty and is not due to exogenous substances or disease processes.

Tabular List of Diseases and Injuries

The following annotation back-references are applicable to this diagnosis code. The Tabular List of Diseases and Injuries is a list of ICD-10-CM codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more.

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Gynecomastia
  • Hypertrophy of breast NOS
  • Massive pubertal hypertrophy of breast

Type 1 Excludes

Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • breast engorgement of newborn P83.4
  • disproportion of reconstructed breast N65.1

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert to ICD-9-CM Code

Source ICD-10-CM CodeTarget ICD-9-CM Code
N62611.1 - Hypertrophy of breast

Patient Education

Breast Diseases

Most women experience breast changes at some time. Your age, hormone levels, and medicines you take may cause lumps, bumps, and discharges (fluids that are not breast milk).

If you have a breast lump, pain, discharge or skin irritation, see your health care provider. Minor and serious breast problems have similar symptoms. Although many women fear cancer, most breast problems are not cancer.

Some common breast changes are:

  • Fibrocystic breast changes - lumpiness, thickening and swelling, often just before a woman's period
  • Cysts - fluid-filled lumps
  • Fibroadenomas - solid, round, rubbery lumps that move easily when pushed, occurring most in younger women
  • Intraductal papillomas - growths similar to warts near the nipple
  • Blocked milk ducts
  • Milk production when a woman is not breastfeeding

NIH: National Cancer Institute

[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.